NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 221 filers reported holding NATERA INC in Q2 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $294,000 | -2.3% | 3,145 | +16.5% | 0.01% | -18.2% |
| Q3 2021 | $301,000 | -6.8% | 2,700 | -5.0% | 0.01% | +10.0% |
| Q2 2021 | $323,000 | +9.1% | 2,843 | -2.5% | 0.01% | 0.0% |
| Q1 2021 | $296,000 | -26.4% | 2,917 | -27.8% | 0.01% | -23.1% |
| Q4 2020 | $402,000 | +10.4% | 4,042 | -19.8% | 0.01% | 0.0% |
| Q3 2020 | $364,000 | +30.5% | 5,038 | -9.8% | 0.01% | +18.2% |
| Q2 2020 | $279,000 | -6.4% | 5,587 | -44.0% | 0.01% | -8.3% |
| Q1 2020 | $298,000 | – | 9,970 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |